Skip to main content
. 2019 Jun 3;14:93. doi: 10.1186/s13014-019-1300-6

Fig. 5.

Fig. 5

The relationship between dose escalation using the motion managed PTV, as a function of PTV reduction as a percentage of the ITV-based PTV (part (a)) and the motion vector magnitude of the GTV (part (b))